Halozyme Therapeutics HALO
NASDAQ HALO
$109.86 +2.92 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Short-term Investments (2013 - 2026)

Updated

Halozyme Therapeutics' Short-term Investments was $67.87 million in Q2 2026, down 86.0% from $486.32 million a year earlier but up 664.8% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Short-term Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Short-term Investments at Halozyme Therapeutics came in at $9 million, down 98.1% from FY2024.

  • Short-term Investments shows a five-year compound annual growth rate of -47.2% (FY2020 to FY2025).
  • In earlier years, Short-term Investments was $480.22 million in FY2024 (+120.7%), $217.63 million in FY2023 (+69.2%), $128.6 million in FY2022 (-79.3%) and $622.2 million in FY2021 (+182.4%).
  • Quarterly Short-term Investments has moved between $8.87 million (Q1 2026) and $668.31 million (Q1 2022) over five years.
  • Compared with a year earlier, Short-term Investments has declined for four straight quarters, with growth averaging 9.0% over the last eight quarters.
  • The best year-over-year quarter for Short-term Investments over five years was Q4 2021 (growth of 182.4%); the worst was Q1 2026 (a decline of 98.4%).
  • Per Business Quant data, HALO's Short-term Investments in the three quarters before Q2 2026 was $8.87 million (Q1 2026), $9 million (Q4 2025) and $282.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Halozyme Therapeutics 12.53 Bn 11.13 Bn 401.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.87 Mn
Mar 31, 2026 8.87 Mn
Dec 31, 2025 9.00 Mn
Sep 30, 2025 282.30 Mn
Jun 30, 2025 486.32 Mn
Mar 31, 2025 571.59 Mn
Dec 31, 2024 480.22 Mn
Sep 30, 2024 511.99 Mn
Jun 30, 2024 341.17 Mn
Mar 31, 2024 298.82 Mn
Dec 31, 2023 217.63 Mn
Sep 30, 2023 209.06 Mn
Jun 30, 2023 127.11 Mn
Mar 31, 2023 179.23 Mn
Dec 31, 2022 128.60 Mn
Sep 30, 2022 118.43 Mn
Jun 30, 2022 118.43 Mn
Mar 31, 2022 668.31 Mn
Dec 31, 2021 622.20 Mn
Sep 30, 2021 324.24 Mn
API Access

Halozyme Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=HALO&period=max&api_key=YOUR_API_KEY